Renal transplant recipients are at high risk for both symptomatic and asymptomatic deep vein thrombosis

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 5, 2006, Pages 988-992

  Poli, Daniela ^a,b   Zanazzi, M ^b   Antonucci, E ^a   Bertoni, E ^b   Salvadori, M ^b   Abbate, R ^a   Prisco, D ^a  

^a Thrombosis Centre   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Asymptomatic venous thromboembolism; Oral anticoagulant therapy; Renal transplant recipients; Symptomatic venous thromboembolism; Venous thromboembolism recurrence

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; CANCER; COHORT ANALYSIS; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HIGH RISK PATIENT; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MUSCLE HEMATOMA; OBSERVATIONAL METHOD; PRIORITY JOURNAL; RECIPIENT; RECURRENCE RISK; RISK ASSESSMENT; RISK FACTOR; SYMPTOMATOLOGY; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

ADOLESCENT; ADULT; AGED; ANTICOAGULANTS; COHORT STUDIES; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RISK FACTORS; VENOUS THROMBOSIS;

EID: 33645652058     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.01917.x     Document Type: Article

References (37)

1. Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M. The coagulo-lytic system and endothelial function in cyclosporine-treated kidney allograft recipients. Transplantation 1996; 62: 828-30.
2. Irish AB, Green FR. Environmental and genetic determinants of the hypercoagulable state and cardiovascular disease in renal transplant recipients. Nephrol Dial Transplant 1997; 12: 167-73.
3. Hryszko T, Malyszko J, Malyszko JS, Brzosko S, Pawlak K, Mysliwiec M. A possible role of thrombin-activatable fibrinolysis inhibitor in disturbances of fibrinolytic system in renal transplant recipients. Nephrol Dial Transplant 2001; 16: 1692-6.
4. Sartori MT, Rigotti P, Marchini F, Spiezia L, Baldan N, Furian L, Varvarikis C, Girolami A. Plasma fibrinolytic capacity in renal transplant recipients: Effect of steroid-free immunosuppression therapy. Transplantation 2003; 75: 994-8.
5. Kazory A, Ducloux D. Acquired hypercoagulable state in renal transplant recipients. Thromb Haemost 2004; 91: 646-56.
6. Venkateswara K, Smith EJ, Alexander JW, Fidler JP, Pemmaraju SR, Pollack VE. Thromboembolic disease in renal allograft recipients. What is its clinical significance? Arch Surg 1976; 111: 1086.
7. Arnadottir M, Bergentz SE, Bergqvist D, Husberg B, Konrad P, Lindholm T. Thromboembolic complications after renal transpalntation: A retrospective analysis. World J Surg 1983; 7: 757-61.
8. Bergqvist D, Bergentz SE, Bornmyr S, Husberg B, Konrad P, Ljungner H. Deep vein thrombosis after renal transplantation: A prospective analysis of frequency and risk factors. Eur Surg Res 1985; 17: 69.
9. Allen RD, Michie CA, Murie JA, Morris PJ. Deep venous thrombosis after renal transplantation. Surg Gynecol Obstet 1987; 164: 137-42.
10. Abbott KC, Cruess DF, Agodoa LY, Sawyers ES, Tveit DP. Early renal insufficiency and late venous thromboembolism after renal transplantation in the United States. Am J Kidney Dis 2004; 43: 120.
11. Poli D, Zanazzi M, Antonucci E, Marcucci R, Rosati A, Bertoni E, Salvadori M, Liotta AA, Abbate R, Prisco D, Gensini GF. High rate of recurrence in renal transplant recipients after a first episode of venous thromboembolism. Transplantation 2005; 80: 789-93.
12. Samama MM, Cohen AT, Darmon JY, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Nguyen H, Olsson CG, Turpie AG, Weisslinger N. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999; 341: 793-800.
13. Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ, for PREVENT Medical Thromboprophylaxis Study Group. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004; 110: 874-9.
14. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med 1988; 318: 1162-73.
15. Moser KM, Fedullo PF, LitteJohn JK, Crawford R. Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis. JAMA 1994; 271: 223-5.
16. Vaitkus PT, Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Goldhaber SZ, PREVENT Medical Thromboprophylaxis Study Group. Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients. Thromb Haemost 2005; 93: 76-79.
17. Kasiske BL, Vazquez MA, Harmon WE, Brown RS, Danovitch GM, Gaston RS, Roth D, Scandling JD, Singer GG. Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol 2000; 11: S1.
18. Prandoni P, Cogo A, Bernardi E, Villalta S, Polistena P, Simioni P, Noventa F, Benedetti L, Girolami A. A simple ultrasound approach for detection of recurrent proximal vein thrombosis. Circulation 1993; 88: 1730.
19. Miniati M, Pistolesi M, Marini C, Di Ricco G, Formichi B, Prediletto R, Allescia G, Tonelli L, Sostman HD, Giuntini C. Value of perfusion lung scan in the diagnosis of pulmonary embolism: Results of the prospective investigative study of acute pulmonary embolism diagnosis (PISA-PED). Am J Respir Crit Care Med 1996; 154: 1387-93.
20. Perrier A, Miron MJ, Desmarais S, De Moerloose P, Slosman D, Didier D, Unger PF, Junod A, Patenaude JV, Bounameaux H. Using clinical evaluation and lung scan to rule out suspected pulmonary embolism: Is it a valid option in patients with normal results of lower limb venous compression ultrasonography? Arch Intern Med 2000; 160: 512-6.
21. Marcucci R, Bertini L, Giusti B, Brunelli T, Fedi S, Cellai AP, Poli D, Pepe G, Abbate R, Prisco D. Thrombophilic risk factors in patients with central retinal vein occlusion. Thromb Haemost 2001; 86: 772-6.
22. Chiarugi L, Prisco D, Antonucci E, Capanni M, Fedi S, Alessandrello Liotta A, Margheri M, Simonetti I, Gensini GF, Abbate R. Lipoprotein (a) and anticardiolipin antibodies are risk factors for clinically relevant restenosis after elective balloon percutaneous transluminal coronary angioplasty. Atherosclerosis 2001; 154: 129-35.
23. Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet 1999; 354: 407.
24. Gouarin S, Vabret A, Gault E, Petitjean J, Regeasse A, Hurault de Ligny B, Freymuth F. Quantitative analysis of HCMV DNA load in whole blood of renal transplant patients using real-time PCR assay. J Clin Virol 2004; 29: 194.
25. Robinson KS, Anderson DR, Gross M, Petrie D, Leighton R, Stanish W, Alexander D, Mitchell M, Flemming B, Gent M. Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: the post-arthroplasty screening study. A randomized, controlled trial. Ann Intern Med 1997; 127: 439-45.
26. Bjorgell O, Nilsson PE, Benoni G, Bergqvist D. Symptomatic and asymptomatic deep vein thrombosis after total hip replacement. Differences in phlebographic pattern, described by a scoring of the thrombotic burden. Thromb Res 2000; 99: 429-38. 429-438
27. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG. Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 338S-400S.
28. Wille-Jorgensen P, Jorgensen LN, Crawford M. Asymptomatic postoperative deep vein thrombosis and the development of postthrombotic syndrome. A systematic review and meta-analysis. Thromb Haemost 2005; 93: 236-41.
29. Lensing AW. Surrogate endpoints for the assessment of efficacy in venous thromboembolism treatment trials. Haemostasis 1998; 28: 127-30.
30. Prandoni P, Villalta S, Bagatella P, Rossi L, Marchiori A, Piccioli A, Bernardi E, Girolami B, Simioni P, Girolami A. The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. Haematologica 1997; 82: 423-8.
31. Kearon C, Ginsberg JS, Hirsh J. The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism. Ann Intern Med 1998; 129: 1044-9.
32. Leizorovicz A, Kassai B, Becker F, Cucherat M. The assessment of deep vein thromboses for therapeutic trials. Angiology 2003; 5: 19-24.
33. Wells PS, Lensing AW, Davidson BL, Prins MH, Hirsh J. Accuracy of ultrasound for the diagnosis of deep venous thrombosis in asymptomatic patients after orthopedic surgery. A meta-analysis. Ann Intern Med 1995; 122: 47-53.
34. Ducloux D, Motte G, Challier B, Gibey R, Chalopin JM. Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: A prospective study. J Am Soc Nephrol 2000; 11: 134-7.
35. Prandoni P, Falanga A, Piccioli P. Cancer and venous thromboembolism. Lancet Oncol 2005; 6: 401-10.
36. Vossen CY, Walker ID, Svensson P, Souto JC, Scharrer I, Preston FE, Palareti G, Pabinger I, van der Meer FJ, Makris M, Fontcuberta J, Conard J, Rosendaal FR. Recurrence rate after a first venous thrombosis in patients with familial thrombophilia. Arterioscler Thromb Vasc Biol 2005; 25: 1992-7.
37. Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 2005; 293: 2352-61.